Squarepoint’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
VCM
VPM
Squarepoint's ELV Position: Q1 2026 in Review
Squarepoint reduced its Elevance Health (ELV) stake by 0.86% in Q1 2026, selling an estimated $18.4K and leaving 6,480 shares worth $1.9M. The position accounts for ﹤0.01% of the portfolio, ranked #2221.
Squarepoint first reported a position in ELV in Q2 2015 and has held it in 40 quarters since. The position peaked at $217M in Q4 2024. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Squarepoint held 6,480 shares of Elevance Health worth $1.9M as of Q1 2026.
- Squarepoint sold 56 Elevance Health shares in Q1 2026, an estimated $18.4K.
- Elevance Health made up ﹤0.01% of Squarepoint's portfolio in Q1 2026, its #2221 holding.
- Squarepoint first reported a position in Elevance Health in Q2 2015 and has held it in 40 quarters since.
- Squarepoint's Elevance Health position peaked at $217M in Q4 2024.
- 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.